As of 2026-01-08, the Intrinsic Value of Terns Pharmaceuticals Inc (TERN) is -4.20 USD. This TERN valuation is based on the model Peter Lynch Fair Value. With the current market price of 40.00 USD, the upside of Terns Pharmaceuticals Inc is -110.51%.
Based on its market price of 40.00 USD and our intrinsic valuation, Terns Pharmaceuticals Inc (TERN) is overvalued by 110.51%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.20 - -4.20 | -4.20 | -110.51% |
| P/E | (16.12) - (16.90) | (16.62) | -141.6% |
| DDM - Stable | (8.65) - (30.82) | (19.73) | -149.3% |
| DDM - Multi | (7.82) - (21.65) | (11.49) | -128.7% |
| Market Cap (mil) | 4,493.92 |
| Beta | 0.82 |
| Outstanding shares (mil) | 112.35 |
| Enterprise Value (mil) | 4,343.22 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.63% |
| Cost of Debt | 5.00% |
| WACC | 6.80% |